Radiation implant for returning prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new type of radiation implant placed directly into the prostate to treat cancer that has come back after initial treatment. It may offer a targeted option for people whose cancer is only in the prostate area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that has returned after your first treatment, confirmed by a biopsy.
- Your PSA level is under 10 ng/mL at the time of the study.
- The cancer is only in the prostate or has spread just slightly outside it, but not to lymph nodes or other organs.
- You are healthy enough for daily activities (ECOG score 0-2) and have a life expectancy of more than 6 months.
- You have not had surgery or low-dose radiation therapy as your first treatment for prostate cancer.
- You are at least 40 years old and agree to use birth control for 3 months after the implant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation using tiny alpha-emitting seeds placed directly into the tumor. It is for people whose prostate cancer came back in the gland after initial treatment but hasn't spread elsewhere.
This trial tests a second, short course of high-dose radiation for men whose prostate cancer has come back only in the prostate area after earlier radiation. It aims to control the cancer while limiting side effects.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial studies high-dose radiation (HDR) given after prostate cancer returns only in the prostate/seminal vesicles. It may help by trying to control the cancer when it has not spread elsewhere, using targeted treatment based on MRI and biopsy proof.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.